Lucien Lebel, an 889-75-18-3 patient, was admitted to the medical service on 3/26/2005 with a CHF flare and discharged on 6/4/2005 with a full code status and disposition of home with services. Medications prescribed upon discharge included ACETYLSALICYLIC ACID 81 MG PO QD, ATENOLOL 50 MG PO QAM Starting Today July, ENALAPRIL MALEATE 10 MG PO QD, LASIX (FUROSEMIDE) 80 MG PO QD Starting Today November, NPH INSULIN HUMAN (INSULIN NPH HUMAN) 60 UNITS SC QAM and QPM, COUMADIN (WARFARIN SODIUM) 5 MG PO QPM, PAXIL (PAROXETINE) 50 MG PO QD, SEROQUEL (QUETIAPINE) 800 MG PO QPM, DEPAKOTE ER (DIVALPROEX SODIUM ER) 1,000 MG PO QPM, LIPITOR (ATORVASTATIN) 60 MG PO QD, and POTENTIALLY SERIOUS INTERACTION: WARFARIN & ATORVASTATIN CALCIUM Reason for override: mda. The patient had a history of Afib, Type 2 DM on insulin, CAD, s/p MI 2000, and A fib/flutter, and was given 25 mg PO Lopressor x 2 in the ED which brought her HR down to 110s. The patient was also prescribed a diet of low cholesterol and saturated fat, ADA 1800 calories per day, 2 grams of sodium, and to measure weight daily, as well as to resume regular exercise, and follow-up appointments were scheduled with Dorsey Deases on 11/2 at 2:30 PM, Dr. Lavern Bringhurst on 2/2, and Dr. Lesley Bertling to draw INR's every 7 days. The patient was advised to follow up with Sol Kragt, the CHF nurse, maintain a careful low salt diet, not drink too many fluids, measure daily weights, be strict about taking insulin, and seek medical attention for any concerning symptoms, with a number of doses required of approximate 4.
Previous atenolol
ATENOLOL 50 MG PO QAM Starting Today July,